Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals?
With its stock down 5.4% over the past month, it is easy to disregard Pfizer (NYSE:PFE). We, however decided to ...
4 Analysts Assess Pfizer: What You Need To Know
Pfizer PFE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Zacks Investment Research on MSN17d
Pfizer (PFE) Stock Moves -0.43%: What You Should Know
The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...
Finbold1d
2 healthcare stocks to buy ahead of Trump’s pharmaceutical tariffs
While tariffs have triggered market volatility, certain pharmaceutical stocks still present strong investment opportunities.
Nasdaq8d
PFE Quantitative Stock Analysis
PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 90% based on the firm’s underlying fundamentals and the stock’s valuation.
Seeking Alpha19d
Pfizer, Arvinas post mixed late-stage trial results for breast cancer therapy (update)
Pfizer (NYSE:PFE) and its partner Arvinas (NASDAQ:ARVN) for the experimental breast cancer drug vepdegestrant announced mixed initial results from a Phase 3 trial for the protein degrader on ...